Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

    NEXT STORY
    Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC
    PREV STORY
    Bone Therapeutics and Rigenerand sign partnership for cell therapy process development
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ADMA Biologics Resubmits Biologics License Application for RI-002

    RAMSEY, N.J. and BOCA RATON, Fla., Oct. 01, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, ...

    author_avatar
    NASDAQ Market News

    Immuron Reports Significant Alleviation of Colitis Symptoms in Preclinical Program

    Results confirm LPS Antagonist action of IMM-124E offers a novel therapeutic approach to induce ...

    author_avatar
    NASDAQ Market News

    Synthorx Reports Second Quarter Financial Results

    author_avatar
    NASDAQ Market News